- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
COVID-19 Vaccine Tipping Points: KFF Data on States at Risk
A number of US states fall below the national average of ~50% adults having received at least 1 dose of COVID-19 vaccine and could be at risk of future virus spread.
In mid-April, researchers at the Kaiser Family Foundation (KFF) estimated that the US as a whole "...will likely reach a tipping point on COVID-19 vaccine enthusiasm in the next 2 to 4 weeks." The "COVID-19 vaccine tipping point" is described as the point at which vaccine supply may begin to outstrip demand.
We are now approaching mid-May and KFF just published research to reveal how the states compare to the US national average on the spectrum of vaccine coverage. Identifying where these differences are greatest, says KFF, is essential to understanding how to focus efforts to increase coverage throughout the country.
The slides below summarize the KFF findings as of April 29, 2021.
Images ©Sebastien Garcia/stock.adobe.com
